explore -WSS

explore

author：focus 2025-10-01 18:03:24 - browse：599

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Why hospitals are withdrawing from US News rankings

focus

WSS

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

WHO calls for emergency meeting on new China virus, as cases spread

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Ending racial health disparities hinges on penalties, political will

hotspot

explore

focus

Anesthesiologist group: stop taking Ozempic before surgery

In early work, researchers turn to CRISPR to treat Alzheimer's

BioMarin wins approval for gene therapy to treat hemophilia A

Ending racial health disparities hinges on penalties, political will

In age of alternative facts, a scholarly course on calling out crap

Why hospitals are withdrawing from US News rankings

Sports medicine is finally prioritizing gender equality

I learned firsthand about improving diversity in clinical trials

New air purifier tech could be key to improving indoor air quality

Biden tests positive for Covid

entertainment

Medicare has a new plan to address drug shortages

Tesla recalling nearly 16,000 of its 2021

Mass General totes up its waste in a move to tackle climate change

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

FDA approves RSV monoclonal antibody for infants, toddlers

entertainment

focus

focus

entertainment